Related Experiment Videos
Endogenous modulation of monoamine oxidase in schizophrenic and normal humans
Abstract:
Plasma from normal subjects and chronic schizophrenic patients produced nearly equal inhibitory effects on platelet and bovine brain monoamine oxidase (MAO) activity. Plasma from controls and patients with high platelet MAO activity caused less decrease in platelet MAO kinetic variables (Km, Vmax) than plasma from subjects with midrange or low MAO activity. When bovine striatal MAO was used, with serotonin as substrate, plasma from schizophrenic patients caused less decrease in Vmax than plasma from controls. These inhibitory effects are associated with the presence in plasma of one or more nonalbumin proteins with low molecular weight.
Insights
Plasma from individuals with schizophrenia and healthy controls equally inhibited monoamine oxidase (MAO) activity. Specific plasma proteins influenced MAO kinetics, suggesting a role in schizophrenia.
Area of Science:
- Biochemistry
- Neuroscience
- Psychiatry
Background:
- Monoamine oxidase (MAO) is a crucial enzyme in neurotransmitter metabolism.
- Altered MAO activity has been implicated in psychiatric disorders, including schizophrenia.
- Plasma factors may influence MAO activity and contribute to disease pathophysiology.
Purpose of the Study:
- To investigate the inhibitory effects of plasma from chronic schizophrenic patients and normal subjects on MAO activity.
- To examine the relationship between plasma MAO inhibitory effects and platelet MAO activity levels.
- To identify potential plasma components responsible for MAO inhibition.
Main Methods:
- Assessing MAO inhibitory effects of plasma from controls and schizophrenic patients on platelet and bovine brain MAO.
- Analyzing kinetic variables (Km, Vmax) of MAO activity.
- Investigating the role of nonalbumin proteins in plasma-mediated MAO inhibition.
Main Results:
- Plasma from normal subjects and schizophrenic patients exhibited similar inhibitory effects on platelet and bovine brain MAO.
- Plasma from individuals with high platelet MAO activity showed less inhibition of platelet MAO kinetics compared to those with lower activity.
- Plasma from schizophrenic patients caused a smaller decrease in Vmax for bovine striatal MAO with serotonin as a substrate compared to controls.
- These inhibitory effects were linked to low molecular weight, nonalbumin proteins present in plasma.
Conclusions:
- Plasma MAO inhibitory activity is comparable between individuals with chronic schizophrenia and healthy controls.
- Non-albumin plasma proteins of low molecular weight are associated with MAO inhibition.
- These findings suggest a potential role for specific plasma proteins in modulating MAO activity in schizophrenia.